Clinical Trials · NCT03541928
Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery
- Phase
- Phase 2
- Recruitment status
- Recruiting
- Sponsor
- The Methodist Hospital Research Institute
- Enrollment
- 60
- Start date
- Aug 2018
- Locations
- 1 site, United States
- Primary endpoint
- Biochemical control rate